Policies, Positions & Case Studies
Pfizer has created the following position papers, policies and case studies to ensure and demonstrate its ethical development of new medicines. Indeed, all of our clinical research must be reviewed by a qualified Independent Ethics Committee or Institutional Review Board.
We strive to maintain the highest ethical, scientific, and clinical standards in all our clinical research around the world. We regularly review our science policies to align them with Pfizer's vision, values, and goals, and with our stakeholders' evolving values.
- Policy on Compassionate Use
- Policy on Compensation to Human Research Subjects in Clinical Studies
- Policy on Compensation to Investigators in Clinical Trials
- Policy on Global Clinical Trial Standards
- Policy on Registration of Studies, Public Disclosure of Results, and Authorship
- Pfizer's Stem Cell Research Policy
- Policy on Use of Human Tissue
- Pfizer Guidelines and Policy on Laboratory Animal Care
Conduct of Clinical Studies
Read Pfizer's statement on the Declaration of Helsinki and the Ethical Conduct of Clinical Studies.
Mulitinational Clinical Trials
Inclusion of emerging markets in development has been ongoing for more than 10 years. This has reduced development times for new medicines, increased knowledge transfer and scientific collaboration, and improved access to new therapies. Learn more about how Pfizer ensures our trials are done ethically and to international standards.
- View our position paper: Globalization of Clinical Trials
NIH Databank position
IRB Accountability position
GCP and HSP Training
Charging for Investigational Drugs
Phase I Trials
Below are 12 case studies illustrating ethical challenges in the conduct of international clinical research and Pfizer's approach. This series of studies is designed to address topics arising throughout the research process:
Before a Clinical Trial
During a Clinical Trial
 |
Quality Management in Clinical Trials |
|
Cultural Issues in Informed Consent |
|
Informed Consent: Why and How? |
|
Malaria Treatment: Better than the Standard of Care |
After a Clinical Trial and the Overall Environment
|
Research on Research: Learning about Phase 1 Trials |
|
Partnering for HIV Prevention — The Case of Maraviroc |
|
Disclosure of Clinical Trials Information |
|
Developing a Stem Cell Research Policy |
Send us your thoughts and questions about our science policies, position papers and case studies.
- Contact Us
- Investors
- Sitemap
- Careers
- Business to Business
- Terms of Use
- Global Network
- Privacy Policy
Copyright © 2002–2009 Pfizer Inc. All rights reserved. This information is intended only for residents of the United States. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries. Pfizer Inc is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
